References
- Desjars P, Pinaud M, Potel G, et al. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987: 15(2): 134–7
- Parker MM, Parrillo J. Septic shock and other forms of distributive shock. In: Parrillo J, ed. Current therapy in critical care medicine. St Louis: Mosby-Year Book, 1987: 44–55
- Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989: 17(5): 426–9
- Meadows D, Edwards JD, Wilkins RG, et al. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988: 16(7): 663–6
- Parrillo J. Norepinephrine therapy of human septic shock: a reappraisal. Update Crit Care Med 1987: 2(11): 1–5
- Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989: 17(2): 179–80
- Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985: 13(6): 492–6
- Martin C, Saux P, Albanese J, et al. A new look at norepinephrine to treat human hyperdynamic septic shock. (Abstr) Anesthesiology 1987: 67(Suppl 3A): A648
- Melchior JC, Pinaud M, Blanloeil Y, et al. Hemodynamic effects of continuous norepinephrine infusion in dogs with and without hyperkinetic endotoxic shock. Crit Care Med 1987: 15(7): 687–91
- Breslow MJ, Miller CF, Parker SD, et al. Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol 1987: 252(2 Pt 2): H291–300
- Hanson GC. Shock and infection. In: Hanson GC, Wright PL, eds. The medical management of the critically ill. New York: Grune & Stratton, 1978: 371–3
- Bourdarias JP, Dubourg O, Gueret P, et al. Inotropic agents in the treatment of cardiogenic shock. Pharmacol Ther 1983: 22(1): 53–79